ArticleClinical and translational medicine2020

Long-term outcomes of relapsed/refractory double-hit lymphoma (r/r DHL) treated with CD19/22 CAR T-cell cocktail therapy.

Jia Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.